NO132395B - - Google Patents
Download PDFInfo
- Publication number
- NO132395B NO132395B NO3994/71A NO399471A NO132395B NO 132395 B NO132395 B NO 132395B NO 3994/71 A NO3994/71 A NO 3994/71A NO 399471 A NO399471 A NO 399471A NO 132395 B NO132395 B NO 132395B
- Authority
- NO
- Norway
- Prior art keywords
- formula
- grams
- infection
- mol
- ether
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims description 11
- FBAOVPVVMDOHPK-UHFFFAOYSA-N 2-(1h-imidazol-2-ylsulfinyl)-1h-imidazole Chemical compound N=1C=CNC=1S(=O)C1=NC=CN1 FBAOVPVVMDOHPK-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 6
- -1 N-substituted imidazoles Chemical class 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 241001480043 Arthrodermataceae Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 208000007163 Dermatomycoses Diseases 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 241000799767 Scutula Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000037304 dermatophytes Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 230000036269 ulceration Effects 0.000 description 3
- MMPYXMNCSDWAGE-UHFFFAOYSA-N 9-butylfluoren-9-ol Chemical compound C1=CC=C2C(CCCC)(O)C3=CC=CC=C3C2=C1 MMPYXMNCSDWAGE-UHFFFAOYSA-N 0.000 description 2
- ZMXJQEIJNHMYDY-UHFFFAOYSA-N 9-methylfluoren-9-ol Chemical compound C1=CC=C2C(C)(O)C3=CC=CC=C3C2=C1 ZMXJQEIJNHMYDY-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000003929 dermatomycosis Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000024386 fungal infectious disease Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N 1,5-naphthalene disulfonic acid Natural products C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 1
- VEYYRLGECBGEQQ-UHFFFAOYSA-N 2-(9-butylfluoren-9-yl)-1H-imidazole Chemical compound C(CCC)C1(C2=CC=CC=C2C=2C=CC=CC12)C=1NC=CN1 VEYYRLGECBGEQQ-UHFFFAOYSA-N 0.000 description 1
- HTXICBBROZOVRK-UHFFFAOYSA-N 2-(9-methylfluoren-9-yl)-1H-imidazole Chemical compound CC1(C2=CC=CC=C2C=2C=CC=CC12)C=1NC=CN1 HTXICBBROZOVRK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010042938 Systemic candida Diseases 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 241001609979 Trichophyton quinckeanum Species 0.000 description 1
- 230000001762 anti-mycelial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 150000005826 halohydrocarbons Chemical class 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- LWLPYZUDBNFNAH-UHFFFAOYSA-M magnesium;butane;bromide Chemical compound [Mg+2].[Br-].CCC[CH2-] LWLPYZUDBNFNAH-UHFFFAOYSA-M 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- DQEUYIQDSMINEY-UHFFFAOYSA-M magnesium;prop-1-ene;bromide Chemical compound [Mg+2].[Br-].[CH2-]C=C DQEUYIQDSMINEY-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003762 total hair loss Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/62—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2053080A DE2053080C3 (de) | 1970-10-29 | 1970-10-29 | N-substituierte Imidazole und ihre Verwendung als Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO132395B true NO132395B (fr) | 1975-07-28 |
| NO132395C NO132395C (fr) | 1975-11-05 |
Family
ID=5786489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO3994/71A NO132395C (fr) | 1970-10-29 | 1971-10-28 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US3778447A (fr) |
| JP (1) | JPS5347104B1 (fr) |
| AT (1) | AT308099B (fr) |
| AU (1) | AU457506B2 (fr) |
| BE (1) | BE774621A (fr) |
| CA (1) | CA994340A (fr) |
| CH (1) | CH562803A5 (fr) |
| CS (1) | CS176174B2 (fr) |
| DD (1) | DD94820A5 (fr) |
| DE (1) | DE2053080C3 (fr) |
| DK (1) | DK138646C (fr) |
| ES (1) | ES396476A1 (fr) |
| FI (1) | FI55499C (fr) |
| FR (1) | FR2111929B1 (fr) |
| GB (1) | GB1338016A (fr) |
| HU (1) | HU162726B (fr) |
| IL (1) | IL38019A0 (fr) |
| NL (1) | NL7114875A (fr) |
| NO (1) | NO132395C (fr) |
| PL (1) | PL81404B1 (fr) |
| SE (1) | SE374919B (fr) |
| ZA (1) | ZA717217B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2650171A1 (de) * | 1976-10-30 | 1978-05-11 | Bayer Ag | Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4169205A (en) * | 1978-10-25 | 1979-09-25 | E. R. Squibb & Sons, Inc. | Imidazole derivatives of 6,11-dihydrodibenz[b,e]oxepines and 6,11-dihydrodibenz[b,e]thiepines |
| GB2060611A (en) * | 1979-08-08 | 1981-05-07 | Squibb & Sons Inc | 2,3-Dihydro-4H-1- benzothiopyran-4-ones and 2,3- dihydro-1H-inden-1-ones |
| DE2932691A1 (de) * | 1979-08-11 | 1981-04-09 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoeherer freisetzung der wirkstoffe |
| US4248878A (en) * | 1979-10-17 | 1981-02-03 | E. R. Squibb & Sons, Inc. | Imidazole derivatives of 1,5,6,11-tetrahydrobenzo[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridines |
| DE3017881A1 (de) * | 1980-05-09 | 1981-11-12 | Bayer Ag, 5090 Leverkusen | Imidazolyl-indeno-thiophene, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4533670A (en) * | 1983-09-21 | 1985-08-06 | Eli Lilly And Company | Anti-convulsant fluorenylalkylimidazole derivatives, compositions, and method of use |
| US4757082A (en) * | 1984-06-18 | 1988-07-12 | Eli Lilly And Company | Method of inhibiting aromatase |
| NZ219311A (en) * | 1986-02-27 | 1989-04-26 | Janssen Pharmaceutica Nv | Imidazoles and herbicidal compositions |
-
1970
- 1970-10-29 DE DE2053080A patent/DE2053080C3/de not_active Expired
-
1971
- 1971-10-12 AU AU34484/71A patent/AU457506B2/en not_active Expired
- 1971-10-21 CA CA125,736A patent/CA994340A/en not_active Expired
- 1971-10-21 US US00191495A patent/US3778447A/en not_active Expired - Lifetime
- 1971-10-26 IL IL38019A patent/IL38019A0/xx unknown
- 1971-10-27 CS CS7565A patent/CS176174B2/cs unknown
- 1971-10-27 AT AT925671A patent/AT308099B/de not_active IP Right Cessation
- 1971-10-27 FI FI3057/71A patent/FI55499C/fi active
- 1971-10-27 CH CH1565171A patent/CH562803A5/xx not_active IP Right Cessation
- 1971-10-28 SE SE7113705A patent/SE374919B/xx unknown
- 1971-10-28 ZA ZA717217A patent/ZA717217B/xx unknown
- 1971-10-28 DD DD158608A patent/DD94820A5/xx unknown
- 1971-10-28 GB GB5016071A patent/GB1338016A/en not_active Expired
- 1971-10-28 BE BE774621A patent/BE774621A/fr unknown
- 1971-10-28 NL NL7114875A patent/NL7114875A/xx not_active Application Discontinuation
- 1971-10-28 JP JP8520671A patent/JPS5347104B1/ja active Pending
- 1971-10-28 HU HUBA2662A patent/HU162726B/hu unknown
- 1971-10-28 DK DK526271A patent/DK138646C/da active
- 1971-10-28 ES ES396476A patent/ES396476A1/es not_active Expired
- 1971-10-28 PL PL1971151261A patent/PL81404B1/pl unknown
- 1971-10-28 NO NO3994/71A patent/NO132395C/no unknown
- 1971-10-29 FR FR7139123A patent/FR2111929B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE774621A (fr) | 1972-02-14 |
| CH562803A5 (fr) | 1975-06-13 |
| DK138646B (da) | 1978-10-09 |
| ZA717217B (en) | 1972-07-26 |
| CS176174B2 (fr) | 1977-06-30 |
| DD94820A5 (fr) | 1973-01-05 |
| SU403176A3 (fr) | 1973-10-19 |
| JPS5347104B1 (fr) | 1978-12-19 |
| NO132395C (fr) | 1975-11-05 |
| AU457506B2 (en) | 1975-01-30 |
| FI55499B (fi) | 1979-04-30 |
| US3778447A (en) | 1973-12-11 |
| DE2053080A1 (de) | 1972-05-04 |
| AU3448471A (en) | 1973-04-19 |
| DE2053080B2 (de) | 1978-12-14 |
| CA994340A (en) | 1976-08-03 |
| FR2111929B1 (fr) | 1975-08-01 |
| FR2111929A1 (fr) | 1972-06-09 |
| DE2053080C3 (de) | 1979-08-23 |
| DK138646C (da) | 1979-03-12 |
| GB1338016A (en) | 1973-11-21 |
| IL38019A0 (en) | 1971-12-29 |
| PL81404B1 (fr) | 1975-08-30 |
| ES396476A1 (es) | 1974-05-01 |
| HU162726B (fr) | 1973-04-28 |
| FI55499C (fi) | 1979-08-10 |
| SE374919B (fr) | 1975-03-24 |
| AT308099B (de) | 1973-06-25 |
| NL7114875A (fr) | 1972-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2041771C3 (de) | derivate | |
| NO980055L (no) | Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav | |
| DE2037610B2 (fr) | ||
| DD148773A5 (de) | Verfahren zur herstellung von imidazol-derivaten | |
| DE2623129A1 (de) | Neue tertiaere imidazolylalkohole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| NO132395B (fr) | ||
| EP0174464B1 (fr) | Benzyl-phtalazinones substitués | |
| DE2522553A1 (de) | Eckige klammer auf 1-hydroximino- 2,2-disubstituiert-5-indanyloxy(oder thio) eckige klammer zu alkansaeuren und verfahren zu ihrer herstellung | |
| NO124372B (fr) | ||
| NO145791B (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| EP0036153B1 (fr) | Diphényl-1,1 (triazol-1,2,4 yl-1 comme agents antimycotiques | |
| DE2333355A1 (de) | Antimikrobielle mittel | |
| DE2932967A1 (de) | Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel | |
| DE1960910C3 (de) | Benzylidenamino-oxyalkancarbonsäuren und deren Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE2128375A1 (de) | Neue basische (Substituiert-alkyliden)amino-oxyalkylcarbonsäureester | |
| NO138025B (no) | Analogifremgangsm}te til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
| JPS6030673B2 (ja) | 抗かび活性を有するエテニルイミダゾ−ル誘導体、その製造法、およびそれを含む製薬組成物その製造に有用な中間物、およびこの中間物の製造法 | |
| NO139784B (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme (1-imidazolyl-(1))-(1-(4`-(4"-klorfenyl)-fenoksy)-3,3-dimetylbutan-2-on og dets salter | |
| DE3026755A1 (de) | Neue 1-substituierte-3-cycloalkyl- sulfonyl-pyrrolidin-2,5-dion-derivate und ihre verwendung als fungizide sowie verfahren zur herstellung der wirkstoffe und der fungiziden mittel | |
| NO140009B (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme (1-imidazolyl-(1))-(2-(4`-(4`-klor-fenyl)-fenoksy)-4,4-dimetyl-pentan-3-on og dets salter | |
| US3814802A (en) | N-substituted imidazoles,as antimycotic agents | |
| FI57946C (fi) | Foerfarande foer framstaellning av antimykotiskt aktiva 1-(dimetylfenyl-fenyl-2(eller 4)-pyridyl-metylimidazoler | |
| DE2347057A1 (de) | Antimikrobielle mittel | |
| DE2143009B2 (de) | In 2,7-Stellung basisch substituierte Thioxanthene, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat | |
| EP0313983A2 (fr) | Utilisation d'alcanols triazolyl pour le traitement de maladies |